News Accord BioPharma and EVERSANA Announce Partnership to Support the Launch of CAMCEVI® for the Treatment of Advanced Prostate Cancer in Adults in the U.S. Jun 29, 2022
News Digital Health Industry Take Note: New HIPAA Comment Opportunity and Guidance Addresses Growing Risk of Cybersecurity Attacks Jun 21, 2022
News MorphoSys Presents Multiple Analyses of the MANIFEST Phase 2 Trial Investigating the Potential of Pelabresib in the Treatment of Myelofibrosis at EHA 2022 Jun 16, 2022
News MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210 Jun 16, 2022
News Sumitomo Pharma Oncology Receives Orphan Drug Designation for TP-3654, an Investigational Oral Inhibitor of PIM Kinases for the Treatment of Myelofibrosis Jun 15, 2022 Posted by Sumitomo Pharma Oncology, Inc.
News Astrocyte Announces Initiation of First-In-Human Phase 1 Study of the Promising Stroke and Traumatic Brain Injury Therapeutic, AST-004 Jun 15, 2022
News Asymmetrex®’s Kinetic Stem Cell (KSC) Counting Technology Is Featured in the Parent’s Guide to Cord Blood Foundation® June Newsletter Jun 15, 2022
News Batavia Biosciences increases capacity for viral vectors and vaccine R&D in Netherlands. Jun 14, 2022
%20(3).png)
